雷帕鸣进医保了吗？

(Rapamune) is suitable for patients 13 years of age or older who have received kidney transplants to prevent organ rejection. Recommended for use in combination with cyclosporine and corticosteroids.

Rapamune inhibits the activation and proliferation of T lymphocytes stimulated by antigens and cytokines (interleukins IL-2, IL-4 and IL-15). It also inhibits the production of antibodies. In cells, rapamune binds to the immunophilin, FK-binding protein-12 (FKBP-12), to generate the FKBP-12 immunosuppressive complex. This complex binds to the mammalian Rapamune BA molecule (mTOR, a key regulatory kinase) and inhibits its activity, thereby inhibiting the progression from G1 to S phase in the cell cycle. So is Rapamune included in medical insurance? Let’s take a look.

Medically insured drugs refer to drugs that are necessary to ensure the clinical treatment of employees and are included in the scope of basic medical insurance benefits. They are divided into Category A and Category B. Since Rapamune cannot be found in the "Basic Medical Insurance Drug Catalog", Rapamune is not yet a medically insured drug. Patients need to pay for it at their own expense. It is recommended to buy it at a regular hospital.

Kidney transplantation is the transplantation of a kidney from a healthy person to a patient with kidney disease and loss of kidney function. It is an effective method to treat chronic renal failure. Rapamune can inhibit the activation and proliferation of T lymphocytes stimulated by antigens and cytokines, and also inhibits the production of antibodies, which can prolong the survival of kidney transplant patients.

In summary, we can know that Rapamune has not yet been included in the ranks of medical insurance. If patients want to buy Rapamune at an affordable price and with ideal efficacy, please consult the Medical Companion Travel Service, and we will provide you with convenient and fast drug purchase channels.